Literature DB >> 19389391

Increased circulating Dickkopf-1 in Paget's disease of bone.

Michael J Marshall1, Sally F Evans, Christopher A Sharp, Diane E Powell, Helen S McCarthy, Michael W J Davie.   

Abstract

UNLABELLED: Dickkopf-1 (Dkk-1) is a secreted inhibitor of Wnt signaling which in adults regulates bone turnover. Dkk-1 over-production is implicated in osteolytic disease where it inhibits bone formation and stimulates bone breakdown. Recently it was reported that osteoblastic cells from Paget's disease of bone (PDB) over-expressed Dkk-1.
OBJECTIVE: To see if increased Dkk-1 was detected in serum from patients with PDB.
RESULTS: Dkk-1 and total serum alkaline phosphatase activity (tsAP) were significantly elevated in sera from PDB patients. Patients with polyostotic PDB had significantly higher levels of tsAP but not Dkk-1, than monostotic patients. TsAP but not Dkk-1, was significantly lower in sera from bisphosphonate treated versus untreated PDB patients. Dkk-1 and tsAP were not significantly correlated.
CONCLUSIONS: Dkk-1 may be a useful biomarker of PDB and we speculate that Dkk-1 may play a central role in the etiology of PDB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389391     DOI: 10.1016/j.clinbiochem.2009.04.007

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  Periostin and sclerostin levels in juvenile Paget's disease.

Authors:  Stergios A Polyzos; Polyzois Makras; Athanasios D Anastasilakis; Gesthimani Mintziori; Marina Kita; Athanasios Papatheodorou; Panagiotis Kokkoris; Evangelos Terpos
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

2.  Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.

Authors:  Luca Idolazzi; Angelo Fassio; Gaia Tripi; Vania Braga; Ombretta Viapiana; Giovanni Adami; Maurizio Rossini; Davide Gatti
Journal:  Clin Rheumatol       Date:  2017-01-05       Impact factor: 2.980

Review 3.  Emerging strategies and therapies for treatment of Paget's disease of bone.

Authors:  Laëtitia Michou; Jacques P Brown
Journal:  Drug Des Devel Ther       Date:  2011-04-26       Impact factor: 4.162

Review 4.  Wnt and the Wnt signaling pathway in bone development and disease.

Authors:  Yiping Wang; Yi-Ping Li; Christie Paulson; Jian-Zhong Shao; Xiaoling Zhang; Mengrui Wu; Wei Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

5.  Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis.

Authors:  S-M Tu; A Som; B Tu; C J Logothetis; M-H Lee; S-Cj Yeung
Journal:  Br J Cancer       Date:  2012-07-17       Impact factor: 7.640

6.  Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study.

Authors:  Jung-Hyun Park; Sura Cho; Sun-Jong Kim; Tae-Dong Jeong; Yeung-Chul Mun; Jin-Woo Kim
Journal:  Osteoporos Int       Date:  2021-09-02       Impact factor: 5.071

Review 7.  Paget's disease of bone: an osteoimmunological disorder?

Authors:  Mohamed S Numan; Nathalie Amiable; Jacques P Brown; Laëtitia Michou
Journal:  Drug Des Devel Ther       Date:  2015-08-14       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.